Skip to content
Screener

Merck & Co. MRK Prepaid & Other Current

Prepaid & Other Current at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.22B-22.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$4.83B+10.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$801.7M+39.6%
Cytokinetics logo
CytokineticsCYTK
$17.99M-10.0%
Phibro Animal Health logo
Phibro Animal HealthPAHC
$55.37M-7.3%
United Therapeutics logo
United TherapeuticsUTHR
$317.3M+38.1%

Other financials

Income statement

See full
Revenue$16.6B+5.1%
Gross profit$12.2B-0.3%
Net income-$1.3B-130%
EPS (diluted)-$0.54-131%

Balance sheet

See full
Cash & equivalents$6.9B-14.6%
Total debt$56.7B+54.0%
Total equity$41.9B-14.4%
Total assets$129.80B+10.4%

Cash flow

See full
Operating cash flow$5.4B+63.1%
CapEx$893.0M+16.9%
Free cash flow$4.5B+77.0%

Valuation

See full
Market cap$316.95B+59.7%
Enterprise value$366.79B+61.4%
P/E99.9×+87.8×
P/S4.8×+1.6×

Profitability

See full
Gross margin73%-3.6pp
Net margin4.8%-21.0pp
FCF margin24.1%+1.0pp

Returns & leverage

See full
Return on equity7%-28.5pp
Debt / equity1.4×+0.6×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The source filing: Merck & Co.’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:11 PM EDT
Fiscal quarter
Q3 FY2028
Calendar quarter
Q3 2028
Accession
0000310158-26-000212
Line itemJune 30, 2026December 31, 2025
Short-term investments292
Accounts receivable (net of allowance for doubtful accounts of $108 in 2026 and $97 in 2025)12,56411,775
Inventories (excludes inventories of $6,381 in 2026 and $5,681 in 2025classified in Other assets - see Note 6)6,2076,658
Other current assets10,76710,518
Total current assets36,67943,516
Investments1,222956
Property, Plant and Equipment, at cost, net of accumulated depreciation of $22,729 in 2026 and $21,914 in 202525,73725,316
Goodwill21,58221,579

Item 1. Financial Statements

FAQ

What is Merck & Co.'s prepaid & other current?
Merck & Co. (MRK) reported prepaid & other current of $10.77B in Q2 2026.
How has Merck & Co.'s prepaid & other current changed year-over-year?
Merck & Co.'s prepaid & other current increased by 7.7% year-over-year, from $10B to $10.77B.
What is the long-term trend for Merck & Co.'s prepaid & other current?
Over 5 years (2020 to 2025), Merck & Co.'s prepaid & other current has grown at a 17.6% compound annual growth rate (CAGR), from $4.67B to $10.52B.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Merck & Co.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude